Keflex now in higher strengths
Advancis Pharmaceutical Corp. has been given the go-ahead to marketits antibiotic Keflex (cephalexin) in two newstrengths-333-mg and 750-mg capsules. The company said thiswill give healthcare providers an easier way to prescribe a totaldaily dose of 1,500 mg.
Keflex now in higher strengths
Advancis Pharmaceutical Corp. has been given the go-ahead to market its antibiotic Keflex (cephalexin) in two new strengths-333-mg and 750-mg capsules. The company said this will give healthcare providers an easier way to prescribe a total daily dose of 1,500 mg. Keflex is approved by the FDA for the treatment of infections caused by susceptible strains of gram-positive and gram-negative aerobes. The first-generation cephalosporin is also available in 250- and 500-mg capsules as well as powder for oral suspension.
To see more Hot off the Press news articles, click here http://www.drugtopics.com/Hot+off+the+Press.
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.
